Skip to main content
Top
Published in: Endocrine 3/2018

01-03-2018 | Endocrine Methods and Techniques

Treatment of benign thyroid nodules by high intensity focused ultrasound (HIFU) at different acoustic powers: a study on in-silico phantom

Authors: Fabiano Bini, Pierpaolo Trimboli, Franco Marinozzi, Luca Giovanella

Published in: Endocrine | Issue 3/2018

Login to get access

Abstract

Background

The non-surgical therapies of benign thyroid nodules are gaining momentum due to the possibility to reduce the nodule’s volume and avoid surgery. As the last technique introduced, high intensity focused ultrasound allows the thermal tissue treatment by directing energy inside the targeted nodule with no invasive instruments. In the present study we applied the Food and Drug Administration high intensity focused ultrasound simulator to in-silico phantom to evaluate the effects obtained by different acoustic powers.

Methods

The simulated layers were water and thyroid tissue. The source was a spherically curved circular transducer with radius r   = 2.3 cm generating a continuous wave beam at a frequency of 3 MHz. The focal distance was 6.5 cm. The sequence included a pulse (8 s) with acoustic power at different value from 5 to 50 W, and a cooling-off interval (32 s).

Results

The use of acoustic power of 5 W allowed to achieve the threshold of temperature for coagulative necrosis (55 °C) at 1 s. The simulation with 50 W showed that temperature was significantly higher (above 300 °C) at 1 s and is maintained at high levels for a long interval.

Conclusion

Since 2016, we treated patients according to the present experience, and a significant reduction of nodule’s volume was observed with good patent’s comfort and no complications (unpublished data). Also, no anesthesia was practiced. We feel that the present data could contribute to develop a high intensity focused ultrasound therapy of benign thyroid nodules free from potential complications.
Literature
1.
go back to reference L. Hegedüs, S.J. Bonnema, F.N. Bennedbaek, Management of simple nodular goiter: current status and future perspectives. Endocr. Rev. 24, 102–132 (2003)CrossRef L. Hegedüs, S.J. Bonnema, F.N. Bennedbaek, Management of simple nodular goiter: current status and future perspectives. Endocr. Rev. 24, 102–132 (2003)CrossRef
2.
go back to reference M.F. Erdogan, A. Gursoy, G. Erdogan, Natural course of benign thyroid nodules in a moderately iodine-deficient area. Clin. Endocrinol. 65, 767–771 (2006)CrossRef M.F. Erdogan, A. Gursoy, G. Erdogan, Natural course of benign thyroid nodules in a moderately iodine-deficient area. Clin. Endocrinol. 65, 767–771 (2006)CrossRef
3.
go back to reference H. Gharib, L. Hegedüs, C.M. Pacella, J.H. Baek, E. Papini, Clinical review: nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J. Clin. Endocrinol. Metab. 98, 3949–3957 (2013)CrossRef H. Gharib, L. Hegedüs, C.M. Pacella, J.H. Baek, E. Papini, Clinical review: nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J. Clin. Endocrinol. Metab. 98, 3949–3957 (2013)CrossRef
4.
go back to reference G. ter Haar, C. Coussios, High intensity focused ultrasound: physical principles and devices. Int. J. Hyperthermia 23, 89–104 (2007)CrossRef G. ter Haar, C. Coussios, High intensity focused ultrasound: physical principles and devices. Int. J. Hyperthermia 23, 89–104 (2007)CrossRef
5.
go back to reference C.M. Pacella, G. Bizzarri, R. Guglielmi, V. Anelli, A. Bianchini, A. Crescenzi, S. Pacella, E. Papini, Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology 217, 673–677 (2000)CrossRef C.M. Pacella, G. Bizzarri, R. Guglielmi, V. Anelli, A. Bianchini, A. Crescenzi, S. Pacella, E. Papini, Thyroid tissue: US-guided percutaneous interstitial laser ablation-a feasibility study. Radiology 217, 673–677 (2000)CrossRef
6.
go back to reference Y.F. Zhou, High intensity focused ultrasound in clinical tumor ablation. World J. Clin. Oncol. 2, 8–27 (2011)CrossRef Y.F. Zhou, High intensity focused ultrasound in clinical tumor ablation. World J. Clin. Oncol. 2, 8–27 (2011)CrossRef
7.
go back to reference O. Esnault, B. Franc, J.P. Monteil, J.Y. Chapelon, High-intensity focused ultrasound for localized thyroid-tissue ablation: preliminary experimental animal study. Thyroid 14, 1072–1076 (2004)CrossRef O. Esnault, B. Franc, J.P. Monteil, J.Y. Chapelon, High-intensity focused ultrasound for localized thyroid-tissue ablation: preliminary experimental animal study. Thyroid 14, 1072–1076 (2004)CrossRef
8.
go back to reference O. Esnault, B. Franc, J.Y. Chapelon, Localized ablation of thyroid tissue by high-intensity focused ultrasound: improvement of noninvasive tissue necrosis methods. Thyroid 19, 1085–1091 (2009)CrossRef O. Esnault, B. Franc, J.Y. Chapelon, Localized ablation of thyroid tissue by high-intensity focused ultrasound: improvement of noninvasive tissue necrosis methods. Thyroid 19, 1085–1091 (2009)CrossRef
9.
go back to reference O. Esnault, B. Franc, F. Ménégaux et al. High intensity focused ultrasound ablation of thyroid nodules: first human feasibility study. Thyroid 21, 965–973 (2011)CrossRef O. Esnault, B. Franc, F. Ménégaux et al. High intensity focused ultrasound ablation of thyroid nodules: first human feasibility study. Thyroid 21, 965–973 (2011)CrossRef
10.
go back to reference O. Esnault, A. Rouxel, E. Le Nestour, G. Gheron, L. Leenhardt, Minimally invasive ablation of a toxic thyroid nodule by high-intensity focused ultrasound. AJNR Am. J. Neuroradiol. 31, 1967–1968 (2010)CrossRef O. Esnault, A. Rouxel, E. Le Nestour, G. Gheron, L. Leenhardt, Minimally invasive ablation of a toxic thyroid nodule by high-intensity focused ultrasound. AJNR Am. J. Neuroradiol. 31, 1967–1968 (2010)CrossRef
11.
go back to reference H. Korkusuz, N. Fehre, M. Sennert, C. Happel, F. Grünwald, Volume reduction of benign thyroid nodules 3 months after a single treatment with high-intensity focused ultrasound (HIFU). Ther. Ultrasound 3, 4 (2015)CrossRef H. Korkusuz, N. Fehre, M. Sennert, C. Happel, F. Grünwald, Volume reduction of benign thyroid nodules 3 months after a single treatment with high-intensity focused ultrasound (HIFU). Ther. Ultrasound 3, 4 (2015)CrossRef
12.
go back to reference H. Korkusuz, N. Fehre, M. Sennert, C. Happel, F. Grünwald, Early assessment of high intensity focused ultrasound treatment of benign thyroid nodules by scintigraphic means. Journal of Ther. Ultrasound 2, 18 (2014)CrossRef H. Korkusuz, N. Fehre, M. Sennert, C. Happel, F. Grünwald, Early assessment of high intensity focused ultrasound treatment of benign thyroid nodules by scintigraphic means. Journal of Ther. Ultrasound 2, 18 (2014)CrossRef
13.
go back to reference R.D. Kovatcheva, J.D. Vlahov, J.I. Stoinov, K. Zaletel, Benign solid thyroid nodules: USguided high-intensity focused ultrasound ablation-initial clinical outcomes. Radiology 276, 597–605 (2015)CrossRef R.D. Kovatcheva, J.D. Vlahov, J.I. Stoinov, K. Zaletel, Benign solid thyroid nodules: USguided high-intensity focused ultrasound ablation-initial clinical outcomes. Radiology 276, 597–605 (2015)CrossRef
14.
go back to reference B.H. Lang, Y.C. Woo, K.W. Chiu, Single-session high-intensity focused ultrasound treatment in large-sized benign thyroid nodules. Thyroid 27, 714–721 (2017)CrossRef B.H. Lang, Y.C. Woo, K.W. Chiu, Single-session high-intensity focused ultrasound treatment in large-sized benign thyroid nodules. Thyroid 27, 714–721 (2017)CrossRef
15.
go back to reference E. Soneson Joshua, A user-friendly software package for HIFU Simulation. AIP Conference Proceedings 1113, 165 (2009) E. Soneson Joshua, A user-friendly software package for HIFU Simulation. AIP Conference Proceedings 1113, 165 (2009)
16.
go back to reference J.C. Bamber, C.R. Hill, Ultrasonic attenuation and propagation speed in mammalian tissues as a function of temperature. Ultrasound Med. Biol. 5, 149–157 (1979)CrossRef J.C. Bamber, C.R. Hill, Ultrasonic attenuation and propagation speed in mammalian tissues as a function of temperature. Ultrasound Med. Biol. 5, 149–157 (1979)CrossRef
17.
go back to reference Civale John, Ian Rivens, Gail ter Haar, Quality assurance for clinical high intensity focused ultrasound fields. Int. J. Hyperthermia 31, 193–202 (2015)CrossRef Civale John, Ian Rivens, Gail ter Haar, Quality assurance for clinical high intensity focused ultrasound fields. Int. J. Hyperthermia 31, 193–202 (2015)CrossRef
18.
go back to reference R. Garberoglio, C. Aliberti, M. Appetecchia, M. Attard, G. Boccuzzi, F. Boraso, G. Borretta, G. Caruso, M. Deandrea, M. Freddi, G. Gallone, G. Gandini, G. Gasparri, C. Gazzera, E. Ghigo, M. Grosso, P. Limone, M. Maccario, L. Mansi, A. Mormile, P.G. Nasi, F. Orlandi, D. Pacchioni, C.M. Pacella, N. Palestini, E. Papini, M.R. Pelizzo, A. Piotto, T. Rago, F. Riganti, L. Rosato, R. Rossetto, A. Scarmozzino, S. Spiezia, O. Testori, R. Valcavi, A. Veltri, P. Vitti, M. Zingrillo, Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement. J. Ultrasound 18, 423–430 (2015)CrossRef R. Garberoglio, C. Aliberti, M. Appetecchia, M. Attard, G. Boccuzzi, F. Boraso, G. Borretta, G. Caruso, M. Deandrea, M. Freddi, G. Gallone, G. Gandini, G. Gasparri, C. Gazzera, E. Ghigo, M. Grosso, P. Limone, M. Maccario, L. Mansi, A. Mormile, P.G. Nasi, F. Orlandi, D. Pacchioni, C.M. Pacella, N. Palestini, E. Papini, M.R. Pelizzo, A. Piotto, T. Rago, F. Riganti, L. Rosato, R. Rossetto, A. Scarmozzino, S. Spiezia, O. Testori, R. Valcavi, A. Veltri, P. Vitti, M. Zingrillo, Radiofrequency ablation for thyroid nodules: which indications? The first Italian opinion statement. J. Ultrasound 18, 423–430 (2015)CrossRef
Metadata
Title
Treatment of benign thyroid nodules by high intensity focused ultrasound (HIFU) at different acoustic powers: a study on in-silico phantom
Authors
Fabiano Bini
Pierpaolo Trimboli
Franco Marinozzi
Luca Giovanella
Publication date
01-03-2018
Publisher
Springer US
Published in
Endocrine / Issue 3/2018
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1350-1

Other articles of this Issue 3/2018

Endocrine 3/2018 Go to the issue

Clinical Management of Endocrine Diseases

Cantú syndrome with coexisting familial pituitary adenoma

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine